News summary

AI helps Stanford scientists discover a “natural Ozempic” with a surprising advantage

Source: Science Daily - Health & Medicine • Published: 04 Nov 2026, 06:57

Summarized by Masters of Longevity from Science Daily - Health & Medicine.

Researchers used AI to identify a peptide that cut appetite and body fat in animals.

AI helps Stanford scientists discover a “natural Ozempic” with a surprising advantage
Key Takeaways
  • AI prediction is reported to have identified a nonincretin anti-obesity peptide.
  • The peptide was found to reduce appetite and body fat in animal studies.
  • Animal results have not established safety or efficacy in humans.
Read the full article at Science Daily - Health & Medicine ↗

Continue exploring

Recommended MoL Picks

MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.